OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 09, 2022
New technologies are treatments are emerging to tackle COVID-19 and its assortment of new variants.
March 03, 2022
Flexible and efficient methods are needed for biopharmaceutical manufacturing.
February 01, 2022
Experience is an invaluable asset for outsourcing partners, particularly as more challenging method development services are in demand.
Shifting demands from industry innovators is leading to an increased need for flexible and agile outsourcing partners offering broad and integrated models.
January 02, 2022
Although mRNA and viral vector vaccines have been top of mind for COVID-19 treatments, other technologies and treatments are emerging—along with new variants.
Modeling techniques can improve process control and monitoring in biopharmaceutical production.
January 01, 2022
Qualified algorithms enable validation of machine learning models that can be used for process optimization.
December 17, 2021
Genezen has opened its new process development and analytical lab for viral vector production.
November 10, 2021
Part 2—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius provide insight and examples about solving critical challenges in both analytics and process development for emerging therapies.
October 29, 2021
Ajinomoto and its subsidiary company, Ajinomoto Genexine, have partnered with Insilico Biotechnology to accelerate and improve process development and production of biologics using digital twin technology.